Homeosyn Italia

Homeosyn Italia is an Italian pharmaceutical company specializing in the development and distribution of homeopathic medicines, food supplements, and medical devices. The company is a recognized leader in Physiological Regulating Medicine (PRM), an innovative therapeutic approach that utilizes low-dose biological molecules such as cytokines, hormones, and growth factors to restore homeostatic balance. Homeosyn offers an extensive portfolio of products, most notably the Syn line of homeopathic complexes and various high-quality nutraceutical formulations. Following its acquisition by Guna S.p.a., the company has leveraged expanded research and distribution capabilities to solidify its position in the integrative medicine sector. Its products are widely used for managing chronic pain, inflammatory conditions, and respiratory health. The company maintains a strong focus on scientific education and clinical research within the field of low-dose pharmacology.